JB Chemicals secures USFDA nod for generic version of Clartin tablet
Mumbai: Drug major, J.B. Chemicals & Pharmaceuticals Limited, has recently announced that the U.S. Food and Drug Administration (USFDA) has approved the Company's Abbreviated New Drug Application (ANDA) for Loratadine Tablets USP 10 mg for the treatment of allergic rhinitis caused by pollen and upper respiratory tract allergy for over-the-counter (OTC) use.This product is generic version...
Mumbai: Drug major, J.B. Chemicals & Pharmaceuticals Limited, has recently announced that the U.S. Food and Drug Administration (USFDA) has approved the Company's Abbreviated New Drug Application (ANDA) for Loratadine Tablets USP 10 mg for the treatment of allergic rhinitis caused by pollen and upper respiratory tract allergy for over-the-counter (OTC) use.
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd